Global Cord Blood Corporation (CORBF)

Global Cord Blood Cash Flow Statement

Financials in millions CNY. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Net Income	501.07	501.07	508.25	470.72	291.12	237.1
Depreciation & Amortization	50.08	50.08	51.64	51.78	52.37	50.59
Share-Based Compensation	0	0	0	0	0	84.27
Other Operating Activities	62.46	62.46	70.82	101.5	448.63	446.81
Operating Cash Flow	613.61	613.61	630.71	624	792.12	818.76
Operating Cash Flow Growth	-2.71%	-2.71%	1.07%	-21.22%	-3.25%	28.41%
Capital Expenditures	-19.64	-19.64	-20.11	-16.06	-30.21	-66.69
Change in Investments	0	0	0	-130	0	0.22
Investing Cash Flow	-19.64	-19.64	-20.11	-146.06	-30.21	-66.48
Dividends Paid	0	0	0	0	-18.17	0
Other Financing Activities	-7.73	-7.73	-6.07	-4.04	-3.02	-2.02
Financing Cash Flow	-7.73	-7.73	-6.07	-4.04	-21.19	-2.02
Exchange Rate Effect	-0.17	-0.17	-1.06	-2.1	6.54	6.54
Net Cash Flow	92.31	92.31	585.19	602.43	747.25	747.25
Free Cash Flow	593.97	593.97	610.6	607.94	761.91	752.07
Free Cash Flow Growth	-2.72%	-2.72%	0.44%	-20.21%	1.31%	22.64%
Free Cash Flow Margin	47.78%	47.78%	52.65%	49.77%	77.21%	80.28%
Free Cash Flow Per Share	4.88	4.88	5.02	5.00	6.31	6.63

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).